๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
To learn if the combination of amivantamab and tepotinib can help to contro...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-06-18
Trial ID
NCT06083857
Treatments Being Tested
The purpose of this study is to see whether the study drug, amivantamab, is...
Status
Active Not Recruiting
Location
University of California, Irvine
Start Date
2021-12-02
Trial ID
NCT05117931
Treatments Being Tested
This study will assess the safety and efficacy of Osimertinib with Amivanta...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-07-18
Trial ID
NCT05801029
Treatments Being Tested
The purpose of this study is to compare the efficacy, as demonstrated by pr...
Status
Active Not Recruiting
Location
City of Hope 2
Start Date
2020-10-13
Trial ID
NCT04538664
Treatments Being Tested
The purpose of this clinical trial is to evaluate the safety and tolerabili...
Status
Active Not Recruiting
Location
Cambridge University Hospitals
Start Date
2024-10-09
Trial ID
NCT06632236
Treatments Being Tested
The purpose of the study is to simplify amivantamab intravenous administrat...
Status
Active Not Recruiting
Location
City of Hope Duarte
Start Date
2022-08-05
Trial ID
NCT05388669
This phase II trial compares the effect of amivantamab and hyaluronidase to...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2026-03-23
Trial ID
NCT07042295
The global objective of this Basket of Basket study is to evaluate the anti...
Status
Recruiting
Location
Institut Gustave Roussy
Start Date
2018-12-10
Trial ID
NCT03767075
Treatments Being Tested
This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-...
Status
Recruiting
Location
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Start Date
2024-11-19
Trial ID
NCT06116682
Treatments Being Tested